Medication

Still antibody-positive after H. pylori treatment?

A positive blood antibody test after H. pylori eradication treatment does not, by itself, establish treatment failure or reinfection. Antibodies can persist for a long time. Assessing eradication requires the right test and a doctor’s interpretation, rather than another course of an old prescription.

SinoCareHub Content Team4 min

Positive antibodies do not prove ongoing infection

In someone who has already received Helicobacter pylori (H. pylori) eradication treatment, positive blood antibodies alone cannot establish that the bacteria remain or that reinfection has occurred. The blood test measures antibodies against H. pylori; it does not directly detect the bacteria.

The World Gastroenterology Organisation guideline notes that antibody levels can persist for years after treatment, so antibody testing is not suitable for assessing eradication.[1] A report saying only “H. pylori antibodies positive” needs to be understood in terms of what that test measures. It does not automatically mean the previous treatment failed.

This article mainly concerns adults who have already received eradication treatment. For someone testing positive for the first time who has not been treated, interpretation depends on the test and clinical situation. The explanation for previously treated patients should not simply be applied to them.

A medical records folder, papers, glasses and pen on a desk (AI-generated illustrative scene)

Follow-up testing asks a different question

After treatment, the question is whether infection can still be detected. A 2021 health guide from the Health Management Center at Beijing Tsinghua Changgung Hospital distinguishes urea breath tests from blood antibody tests and states that antibody testing cannot be used to check eradication after treatment.[2]

Non-invasive methods used to assess eradication include the urea breath test and stool antigen test.[1,3] “Stool antigen” and “blood antibody” may sound similar, but they detect different things and serve different purposes. A positive result on one cannot be treated as equivalent to a positive result on the other.

If the clinical situation itself requires gastroscopy, the doctor may also assess infection through biopsy-related testing. Not everyone needs another gastroscopy just to check H. pylori eradication.[1,3] The choice depends on the underlying stomach condition, current circumstances and the receiving facility’s resources.

When bringing previous reports to China for further assessment, keep the complete test names and dates. These are more useful than saying “it was positive before and is positive again.” Whether a report says antibody, antigen or urea breath test changes how the doctor interprets the two results.

Medicines can affect the result

Recent antibiotics, bismuth-containing medicines and some acid-suppressing medicines can interfere with follow-up tests such as the breath test, causing a false negative: infection is present but is not detected.[1,3] Appropriate testing therefore also depends on the doctor knowing about previous treatment and current medicines.

Keep the original eradication prescription, what you actually took and previous follow-up results together using the medical records preparation guide. Put current stomach medicines, antibiotics and other medicines on your medication list. Also explain any missed doses, interruptions or changes caused by side effects.

This information helps the receiving care team decide how to arrange testing and whether further assessment is needed. Ask your doctor about test preparation, any medicine changes and your individual treatment conclusion. Do not stop medicines yourself for a test or repeat an old prescription simply because antibodies are positive.

Need help?

Tell us about your situation and needs. Incomplete records are welcome.

We will contact you. The hospital confirms acceptance, care plans and costs.

Sources and references

  1. World Gastroenterology Organisation: Helicobacter pylori online guideline, sections 6.2–6.4, especially 6.3, “Testing to assess the outcome after eradication therapy”; accessed 2026-11-02. Supports antibody persistence, eradication testing, the context for gastroscopy and medicine interference. This article provides no pre-test medicine-stopping timetable.
  2. Health Management Center, Beijing Tsinghua Changgung Hospital: Health guidance on H. pylori infection, 2021-06-10, section II on monitoring infection. Supports the different purposes of tests described by a Chinese hospital; older patient education does not establish 2026 appointment rules, a uniform treatment regimen or acceptance of patients.
  3. American College of Gastroenterology: ACG Guideline on Treatment of Helicobacter pylori—New Recommendations… Will Practice Change?, 2024-09-17; official commentary on the 2024 guideline, eradication confirmation paragraph under Results. Supports test methods and medicine interference; North American antibiotic regimens and dosing arrangements are not presented as prescriptions for China.
Contact Us